Patents by Inventor Richard Anthony Vere-Hodge

Richard Anthony Vere-Hodge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of (R)-Penciclovir Triphosphate for the Manufacture of a Medicament for the Treatment of Viral Diseases
    Publication number: 20130281470
    Abstract: A method of treatment of: i) HIV-1 infections in mammals, including humans; or ii) HBV infections in mammals, including humans; which method comprises the administration to the human in need of such treatment, an effective amount of the (R)-enantiomer of the triphosphate of a compound of formula (A) or a pharmaceutically acceptable salt thereof; and compounds for use in the method.
    Type: Application
    Filed: June 19, 2013
    Publication date: October 24, 2013
    Applicant: Novartis AG
    Inventors: Richard Anthony Vere Hodge, Raymond Schinazi
  • Use of (R)-Penciclovir Triphosphate for the Manufacture of a Medicament for the Treatment of Viral Diseases
    Publication number: 20110092458
    Abstract: A method of treatment of: i) HIV-1 infections in mammals, including humans; or ii) HBV infections in mammals, including humans; which method comprises the administration to the human in need of such treatment, an effective amount of the (R)-enantiomer of the triphosphate of a compound of formula (A) or a pharmaceutically acceptable salt thereof; and compounds for use in the method.
    Type: Application
    Filed: December 22, 2010
    Publication date: April 21, 2011
    Inventors: Richard Anthony Vere Hodge, Raymond F. Schinazi
  • Use of (R)-peniciclovir triphosphate for the manufacture of a medicament for the treatment of viral diseases
    Patent number: 7045525
    Abstract: A method of treatment of: i) HIV-1 infections in mammals, including humans; or ii) HBV infections in mammals, including humans; which method comprises the administration to the human in need of such treatment, an effective amount of the (R)-enantiomer of the triphosphate of a compound of formula (A) or a pharmaceutically acceptable salt thereof; and compounds for use in the method.
    Type: Grant
    Filed: April 23, 1996
    Date of Patent: May 16, 2006
    Assignee: Novartis AG
    Inventors: Richard Anthony Vere Hodge, Raymond F Schinazi
  • Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections
    Patent number: 6683084
    Abstract: The use of a compound of formula (A) or a bioprecursor, or a pharmaceutically acceptable salt, phosphate ester and/or acyl derivative of either of the foregoing for use in the prophylactic treatment of HHV-6 infection.
    Type: Grant
    Filed: February 16, 2000
    Date of Patent: January 27, 2004
    Assignee: Novartis International Pharmaceutical Ltd.
    Inventors: Richard Anthony Vere Hodge, Malcolm Richard Boyd
  • Use of penciclovir for the treatment of human herpes-virus-8
    Patent number: 6489330
    Abstract: The present invention is directed to the use of a compound of Formula (A), or a bioprecursor, or a pharmaceutically acceptable salt, phosphate ester and/or acyl derivative of either of the foregoing in the manufacture of a medicament for use in the treatment, including prophylaxis of HHV-8 infection.
    Type: Grant
    Filed: December 29, 1999
    Date of Patent: December 3, 2002
    Assignee: Novartis International Pharmaceutical Ltd.
    Inventors: Klaus Max Esser, Richard Anthony Vere Hodge
  • Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections
    Patent number: 6057327
    Abstract: The use of a compound of formula (A) or a bioprecursor, or a pharmaceutically acceptable salt, phosphate ester and/or acyl derivative of either of the foregoing in the manufacture of a medicament for use in the treatment (including prophylaxis) of HHV-6 infection.
    Type: Grant
    Filed: July 29, 1997
    Date of Patent: May 2, 2000
    Assignee: SmithKline Beecham plc
    Inventors: Richard Anthony Vere Hodge, Malcolm Richard Boyd
  • Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infection
    Patent number: 6051579
    Abstract: The use of a compound of formula (A): ##STR1## or a bioprecursor, or a pharmaceutically acceptable salt, phosphate ester and/or acyl derivative of either of the foregoing in the manufacture of a medicament for use in the treatment (including prophylaxis) of HHV-7 infection.
    Type: Grant
    Filed: December 10, 1998
    Date of Patent: April 18, 2000
    Assignee: SmithKline Beecham plc
    Inventor: Richard Anthony Vere Hodge
  • Treatment of a latent infection of herpes virus
    Patent number: 5916893
    Abstract: A method for the treatment of latent infection of herpesviruses in mammals, including humans, which method comprises administering to the mammal in need of such treatment, an effective amount of a compound of formula (A): ##STR1## or a bioprecursor, or a pharmaceutically acceptable salt, phosphate ester and/or acyl derivative of either of the foregoing.
    Type: Grant
    Filed: April 25, 1997
    Date of Patent: June 29, 1999
    Assignee: SmithKline Beecham p.l.c.
    Inventors: Hugh John Field, Alana Maureen Thackray, Teresa Helen Bacon, David Sutton, Richard Anthony Vere Hodge
  • Treatment of a latent infection of herpes viruses
    Patent number: 5840763
    Abstract: A method for the treatment of latent infection of herpesviruses in mammals, including humans, which method comprises administering to the mammal in need of such treatment, an effective amount of a compound of formula (A): ##STR1## or a bioprecursor, or a pharmaceutically acceptable salt, phosphate ester and/or acyl derivative of either of the foregoing.
    Type: Grant
    Filed: September 1, 1995
    Date of Patent: November 24, 1998
    Assignee: SmithKline Beecham plc
    Inventors: Hugh John Field, Alana Maureen Thackray, Teresa Helen Bacon, David Sutton, Richard Anthony Vere Hodge
  • Pharmaceutical treatment
    Patent number: 5674869
    Abstract: Use of a guanine derivative or a prodrug thereof in the treatment of viral infections.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: October 7, 1997
    Assignee: Beecham Group plc
    Inventors: Martin David John Kenig, Richard Anthony Vere Hodge
  • Antiviral ionic complexes of double-standard RNA
    Patent number: 4018916
    Abstract: Ionic complexes of double-stranded ribonucleic acids in which the cations are ammonium polymer polycations, demonstrate antiviral activity.
    Type: Grant
    Filed: June 25, 1975
    Date of Patent: April 19, 1977
    Assignee: Beecham Group Limited
    Inventor: Richard Anthony Vere Hodge
  • Ionic complexes of double-stranded ribonucleic acid
    Patent number: 3978043
    Abstract: Ionic complexes of double-stranded ribonucleic acids in which the cations are ammonium polymer polycations, demonstrate antiviral activity.
    Type: Grant
    Filed: January 27, 1975
    Date of Patent: August 31, 1976
    Assignee: Beecham Group Limited
    Inventor: Richard Anthony Vere-Hodge